Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
Resource Type
Article
Authors
Earl, Helena M ; Hiller, Louise ; Howard, Helen C ; Dunn, Janet A ; Young, Jennie ; Bowden, Sarah J ; McDermaid, Michelle ; Waterhouse, Anna K ; Wilson, Gregory ; Agrawal, Rajiv ; O'Reilly, Susan ; Bowman, Angela ; Ritchie, Diana M ; Goodman, Andrew ; Hickish, Tamas ; McAdam, Karen ; Cameron, David ; Dodwell, David ; Rea, Daniel W ; Caldas, Carlos ; Provenzano, Elena ; Abraham, Jean E ; Canney, Peter ; Crown, John P ; Kennedy, M John ; Coleman, Robert ; Leonard, Robert C ; Carmichael, James A ; Wardley, Andrew M ; Poole, Christopher J
Source
In The Lancet Oncology June 2017 18(6):755-769
Subject
Primary Research Articles
Language
ISSN
1470-2045